Enter multiple symbols separated by commas

Government Agencies FDA


  • FDA’s Margaret Hamburg Takes On Drug Shortages Friday, 24 Feb 2012 | 1:19 PM ET
    Margaret Hamburg, MD and Commissioner of FDA

    Generic drugs are in focus at Generic Pharmaceutical Association's annual meeting in Orlando, Florida. The hot button issue: backlog of generic drug applications at the Food & Drug Administration.

  • Cramer on Vivus Stock Victory Thursday, 23 Feb 2012 | 7:15 PM ET

    What investors should take away from Vivus, as shares soar on FDA nod.

  • Roche: Beware of Fake Avastin Wednesday, 15 Feb 2012 | 11:10 AM ET
    Roche: Beware of Fake Avastin

    A serious warning is out to patients, doctors and hospitals telling everyone to beware of a fake version of Roche's cancer-fighting drug Avastin. Insight with Scott Gottlieb, MD.

  • Health Care & the State of Biotech Monday, 9 Jan 2012 | 5:19 PM ET
    Health Care & the  State of Biotech

    Richard Pops, Alkermes chairman & CEO, discusses the challenges facing the health care industry; FDA approval of a once weekly diabetes drug, and other promising new drug candidates.

  • vivus_200.jpg

    The drug developer's stock took a hit Thursday, after data was released linking an ingredient in its weight loss treatment to an increased risk of birth defects.

  • Amylin CEO on Exenatide Tuesday, 8 Nov 2011 | 5:53 PM ET
    Amylin CEO on Exenatide

    Dan Bradbury, Amylin CEO, discusses paying Lilly $250M upfront and $1.2B of future sales for the rights to Exenatide, the once weekly version of diabetes drug, Byetta, that's pending FDA approval.

  • Ex-Goldman Board Member Surrenders in Trading Case Wednesday, 26 Oct 2011 | 8:56 AM ET
    Rajat Gupta

    A former Goldman Sachs board member on Wednesday surrendered to federal authorities to face criminal charges stemming from a massive hedge fund insider trading case.

  • Listeria Outbreak Traced to Cantaloupe Packing Shed Thursday, 20 Oct 2011 | 10:35 AM ET

    A nationwide listeria outbreak that has killed 25 people who ate tainted cantaloupe was probably caused by unsanitary conditions in the packing shed of the Colorado farm where the melons were grown, federal officials said Wednesday. The New York Times reports.

  • surgeon_OR2_200.jpg

    The federal government has received a surge in complaints in recent months about failed hip replacements, suggesting that serious problems persist with some types of artificial hips even as researchers scramble to evaluate the health dangers.  The New York Times reports.

  • Scrapping Regulations Will Save Businesses $10 Billion Tuesday, 23 Aug 2011 | 12:54 PM ET
    President Barack Obama

    The Obama administration revealed plans Tuesday to cut or roll back hundreds of federal regulations, saying it hoped to save businesses $10 billion and spur job growth.

  • On Food Safety, a Long List but Little Money Tuesday, 23 Aug 2011 | 9:32 AM ET

    The Food and Drug Administration is taking on an expanded mission when regulators have little hope for more funding and may even see their budgets cut, the New York Times reports.

  • Insider Trading: CNBC Explains Thursday, 18 Aug 2011 | 11:07 AM ET

    People usually think of insider trading as illegally manipulating stock sales for huge profits. But it can also be legal. So just what is insider trading? When can it be legal? Here are the details.

  • Cramer Highlights Edwards Lifesciences Wednesday, 17 Aug 2011 | 6:41 PM ET

    The market has given investors a great opportunity to buy this stock at discount, the "Mad Money" host said.

  • microscope_200.jpg

    Swiss drugs industry supplier Lonza is to buy U.S.-listed Arch Chemicals for some $1.2 billion, creating the world's largest player in the microbial control market, the groups said on Monday.

  • Lilly Protects Research Budget as Generics Loom Thursday, 30 Jun 2011 | 7:17 AM ET

    Eli Lilly signaled it could maintain or even boost research spending through 2014, even as company sales and earnings tumble due to expected generic competition for its biggest-selling medicines.

  • Breast Cancer Drug Avastin Not Effective: FDA Panel Wednesday, 29 Jun 2011 | 3:35 PM ET

    A panel of federal cancer experts says the best-selling cancer drug in the world should no longer be approved to treat breast cancer because it is ineffective and causes dangerous side effects.

  • Allen Stanford

    The court-appointed receiver who is recovering assets for investors in Allen Stanford's alleged Ponzi scheme is demanding that Libya's sovereign wealth funds return millions of dollars they somehow managed to withdraw just before the firm blew up in 2009, CNBC has learned.

  • FDA Says Some Chicken Meat May Contain Arsenic Wednesday, 8 Jun 2011 | 2:36 PM ET

    The Food and Drug Administration says some chicken meat may contain small amounts of arsenic, though the agency is stressing that the amount is too tiny to be dangerous to people who eat it.

  • Cancer Drug Targets Tumor Cells Monday, 6 Jun 2011 | 12:55 PM ET
    Cancer Drug Targets Tumor Cells

    Clay Siegall, Seattle Genetics CEO discussing the next generation of drugs in the battle against cancer.

  • Shares of Optimer Jump on FDA Drug Approval Friday, 27 May 2011 | 5:37 PM ET

    Dificid is the first new FDA- drug approved for the infection in nearly 25 years, according to Optimer Pharmaceuticals.